Abstract:
PURPOSE: A novel pyrollo[3,2-b]pyridine derivative and a pharmaceutical composition for preventing or treating melanoma containing the same are provided to ensure high anti-proliferative activity to melanoma cells. CONSTITUTION: A pyrollo(3,2-b)pyridine derivative is denoted by chemical formula 1. A method for preparing the pirrolo(3,2,-b)pyridine derivative comprises: a step of coupling 1-iodine-4-nitrobenze to a compound of chemical formula 2 to obtain a compound of chemical formula 3; a step of reducing the compound of chemical formula 3 to obtain a compound of chemical formula 4; and a step of coupling the compound of chemical formula 4 with a phenylcarboxylic acid or amine derivative which trifluoromethyl, halogen, morpholine, piperazine. A pharmaceutical composition for preventing or treating melanoma contains the pyrollo(3,2-b)pyridine derivative or pharmaceutically acceptable salt as an active ingredient.
Abstract:
PURPOSE: A method for coating heparin on the surface of a stent is provided to maintain a blood clot coagulation effect by improving heparin attachment stability. CONSTITUTION: A method for coating heparin on the surface of a stent is as follows. A coating solution is prepared by adding EDC(1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) and NHS(N-hydroxysulfosuccinimide) to a mixture solution of heparin and dopamine. A metal stent is dipped in the coating solution. The metal stent is made of a material selected from a group consisting of stainless steel, Co-Cr alloy, tantalum, and gold.
Abstract:
본 발명은 신규 피롤로[3,2-b]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물에 관한 것으로, 더욱 상세하게는 하기 화학식 1로 표시되는 신규 피롤로[3,2-b]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물에 관한 것이다. 본 발명에 따른 피롤로[3,2-b]피리딘 유도체는 흑색종 세포에 대하여 뛰어난 흑색종 항증식 활성을 나타내며, 종래 흑색종 치료제로 사용되는 소라페닙에 비하여 10배 이상의 흑색종 항증식 활성을 나타내기 때문에 흑색종 예방 또는 치료에 유용하게 사용될 수 있다. [화학식 1]
(상기 화학식 1에서 R 1 및 R 2 는 본 명세서에서 정의한 바와 같다) 피롤로[3,2-b]피리딘 유도체, DTIC, 흑색종, 항증식효과
Abstract:
PURPOSE: A phytoncide releasing stent is provided to more efficiently emit phytoncide in a living body. CONSTITUTION: A phytoncide releasing stent comprises a coating layer in which the mixture of phytoncide and biodegradable polymer is coated on the surface thereof. A stent is made of a metal material selected from stainless steel, cobalt-chrome, platinum-chrome, tantalum, titanium, nitinol, gold, platinum, silver, and their alloy. The biodegradable polymer is selected from a group consisting of polyglycolic acid, poly-L-lactic acid, poly-D-lactic acid, poly-D,L-lactic acid, poly-e-carprolactone, polylactic acid-glycolic acid copolymer, poly-L-lactic acid-e-caprolactone copolymer, polyethylene glycol, polyamino acid, polyanhydride, polyortho ester, polydioxanone, polyphosphazene, cellulose acetate butylate, cellulose triacetate, and their copolymer.